From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, Charles River Laboratories Research Models and Preclinical Services including Phase I Clinical Services, are unequaled in the drug development business.
Who Our Customers Are
Our customer base includes every major pharmaceutical and biotechnology company worldwide as well as leading academic institutions and government research centers.
Why Pharmaceutical and Biotechnology Companies Outsource Drug Discovery and Development Research to Us
Outsourcing helps pharmaceutical and biotech companies put more drug candidates in the pipeline, move those compounds through the pipeline faster, and at the same time control development costs. In many cases, the research programs at pharmaceutical companies are operating at or near capacity. Outsourcing helps them pursue the development of a greater number of compounds without taking on the added capital expense of constructing new facilities, hiring new people, and outfitting new labs with expensive equipment. In addition, outsourcing allows pharmaceutical and biotech companies to focus their internal R&D assets on core activities.